Cancer Genetics and Epigenetics, 2025, Vol.13, No.3, 117-125 http://medscipublisher.com/index.php/cge 124 Grzybowska E., Trębińska-Stryjewska A., Fabisiewicz A., and Szostakowska M., 2018, Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals, Breast Cancer Research and Treatment, 173: 489-497. https://doi.org/10.1007/s10549-018-5023-4 Hanker A., Arteaga C., and Sudhan D., 2020, Overcoming endocrine resistance in breast cancer, Cancer Cell, 37(4): 496-513. https://doi.org/10.1016/j.ccell.2020.03.009 Hartkopf A.D., Grischke E., and Brucker S.Y., 2020, Endocrine-resistant breast cancer: mechanisms and treatment, Breast Care, 15(4): 347-354. https://doi.org/10.1159/000508675 Hubalek M., Brunner C., and Marth C., 2012, Evolving strategies to overcome endocrine resistance in breast cancer, Memo-Magazine of European Medical Oncology, 5(2): 105-109. https://doi.org/10.1007/s12254-012-0003-6 Lambertini M., Blondeaux E., Bisagni G., Mura S., De Placido S., De Laurentiis M., Fabi A., Rimanti A., Michelotti A., Mansutti M., Russo A., Montemurro F., Frassoldati A., Durando A., Gori S., Turletti A., Tamberi S., Urracci Y., Fregatti P., Razeti M.G., Caputo R., De Angelis C., Sanna V., Gasparini E., Agostinetto E., de Azambuja E., Poggio F., Boni L., and Del Mastro L., 2023, Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the mammella interGruppo (MIG) and gruppo italiano mammella (GIM) studies, eClinicalMedicine, 59: 101931. https://doi.org/10.1016/j.eclinm.2023.101931 Lu J., Spicer D., and D'souza A., 2018, Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer, Journal of Hematology and Oncology, 11(1): 80. https://doi.org/10.1186/s13045-018-0620-6 Li M.L., 2024, Advancements in mRNA vaccines for breast cancer treatment: current trends and future prospects, Journal of Vaccine Research, 14(3): 147-156. https://doi.org/10.5376/jvr.2024.14.0015 Miyoshi Y., and Araki K., 2018, Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer, Breast Cancer, 25(4): 392-401. https://doi.org/10.1007/s12282-017-0812-x Murphy C., and Dickler M., 2016, Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies, Endocrine-Related Cancer, 23(8): R337-R352. https://doi.org/10.1530/ERC-16-0121 Nicolini A., Scatena C., Ferrari P., and Schiavone M., 2025, Molecular mechanisms and therapeutic strategies to overcome resistance to endocrine therapy and cdk4/6 inhibitors in advanced ER+/HER2−breast cancer, International Journal of Molecular Sciences, 26(7): 3438. https://doi.org/10.3390/ijms26073438 Nwachukwu J., Kim Y., Rangarajan E., Yao X., Lin C., Izard T., Kastrati I., Strid T., Frasor J., Nowak J., Leong H., Stende J., Yakir M., Nettles K., Glass C., Srinivasan S., Carlson K., Grant B., and Katzenellenbogen J., 2017, Structural and molecular mechanisms of cytokine-mediated endocrine resistance in human breast cancer cells, Molecular Cell, 65(6): 1122-1135. https://doi.org/10.1016/j.molcel.2017.02.008 Perrone F., Giordano A., De Luca A., Normanno N., De Matteis A., De Maio E., and Di Maio M., 2005, Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer, Endocrine-Related Cancer, 12(4): 721-747. https://doi.org/10.1677/ERC.1.00857 Ramaswamy B., and Zhao M., 2014, Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer, World Journal of Clinical Oncology, 5(3): 248-262. https://doi.org/10.5306/wjco.v5.i3.248 Rani A., Stebbing J., Giamas G., and Murphy J., 2019, Endocrine resistance in hormone receptor positive breast cancer–from mechanism to therapy, Frontiers in Endocrinology, 10: 245. https://doi.org/10.3389/fendo.2019.00245 Sahin O., Saatci O., and Huynh-Dam K., 2021, Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies, Journal of Molecular Medicine, 99: 1691-1710. https://doi.org/10.1007/s00109-021-02136-5 Sewasew D., and Belachew E., 2021, Molecular mechanisms of endocrine resistance in estrogen-receptor-positive breast cancer, Frontiers in Endocrinology, 12: 599586. https://doi.org/10.3389/fendo.2021.599586 Sharma M., Pruitt K., and Rasha F., 2021, Mechanisms of endocrine therapy resistance in breast cancer, Molecular and Cellular Endocrinology, 532: 111322. https://doi.org/10.1016/j.mce.2021.111322 Sutherland R., and Musgrove E., 2009, Biological determinants of endocrine resistance in breast cancer, Nature Reviews Cancer, 9: 631-643. https://doi.org/10.1038/nrc2713 Tyson J., Dixon J., and Clarke R., 2015, Endocrine resistance in breast cancer-an overview and update, Molecular and Cellular Endocrinology, 418: 220-234. https://doi.org/10.1016/j.mce.2015.09.035 Tanwar P., Gupta R., Hussain S., Aftab M., Sisodiya S., and Khan A., 2025, Mechanisms and therapeutic strategies for endocrine resistance in breast cancer: a comprehensive review and meta-analysis, Cancers, 17(10): 1653. https://doi.org/10.3390/cancers17101653
RkJQdWJsaXNoZXIy MjQ4ODYzNA==